Imidazyl

Naphazoline Nitrate, the active ingredient in Imidazyl, is a alpha‑adrenergic agonist presented as an eye drop for ocular use. It reduces conjunctival redness and swelling in adults and children. GNH USA supplies Imidazyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imidazyl is an ocular decongestant that acts on the conjunctival vasculature to alleviate redness and swelling. - Ocular redness: provides rapid reduction of visible redness by constricting conjunctival blood vessels. - Conjunctival hyperemia: diminishes vessel dilation, improving eye appearance and comfort. - Eye irritation due to minor inflammation: helps relieve mild swelling and redness associated with irritants.

Imidazyl may cause a range of ocular and systemic reactions.

Common Side Effects: - Stinging or burning sensation upon instillation. - Transient blurred vision. - Mild eye itching or dryness. - Temporary headache.

Serious or Rare Side Effects: - Increased intra‑ocular pressure, especially in glaucoma patients. - Severe allergic reaction (e.g., swelling, rash, difficulty breathing). - Corneal ulceration or persistent eye pain.

Use Imidazyl with care and observe the following precautions. - Avoid use in patients with narrow‑angle glaucoma: risk of elevated intra‑ocular pressure. - Do not use if known hypersensitivity to naphazoline or any excipient: may trigger allergic response. - Limit application to 3‑4 times daily: prolonged use can cause rebound redness. - Do not apply to infected, ulcerated, or severely inflamed eyes: may worsen condition. - Store at room temperature: keep in the original container, protect from light and moisture.

Imidazyl can interact with other medications affecting vascular tone.

Major Interactions (Avoid): - Concurrent use with MAO inhibitors: may potentiate vasoconstrictive effects. - Use with other ocular decongestants: risk of additive vasoconstriction. - Combination with sympathomimetic eye drops: may cause excessive vasoconstriction.

Moderate Interactions (Monitor Closely): - Use with topical anesthetics: may increase corneal toxicity. - Concurrent systemic alpha‑adrenergic agonists: monitor blood pressure for additive effects.